AACR Annual Meeting 2026 Press Program
The American Association for Cancer Research hosted the 117th Annual Meeting from April 17-22, 2026, at the San Diego Convention Center in San Diego, California.
The AACR Annual Meeting is the focal point of the cancer research community. This year’s meeting offered approximately 23,000 researchers, physicians, and advocates from around the world an opportunity to share and discuss the latest advances in basic, translational, and clinical cancer research and cancer-related population sciences.
To help reporters plan coverage of the meeting, the AACR prepared the following press program.
PRESS CONFERENCE 1
AACR Annual Meeting Clinical Trials Committee Cochair Jayesh Desai, MD, Peter MacCallum Cancer Centre, moderated the first press conference.
- Presented by Byoung Chul Cho, MD, PhD, Yonsei Cancer Center, Yonsei University College of Medicine
- Presented by Jonathan W. Riess, MD, UC Davis Comprehensive Cancer Center
New Antibody-drug Conjugate Shows Clinical Benefit for Advanced Platinum-resistant Ovarian Cancer
- Presented by Tao Zhu, MD, Zhejiang Cancer Hospital
PRESS CONFERENCE 2
AACR Annual Meeting Clinical Trials Committee Cochair Ecaterina E. Dumbrava, MD, moderated the second press conference.
BCMA-directed CAR T-cell Therapy May Be Effective Against High-risk Smoldering Multiple Myeloma
- Presented by Omar Nadeem, MD, Dana-Farber Cancer Institute, Harvard Medical School.
- Presented by Marco A. De Velasco, PhD, Kindai University in Japan
- Presented by Rukhmini Bandyopadhyay, PhD, The University of Texas MD Anderson Cancer Center
PRESS CONFERENCE 3
Former AACR President Elizabeth M. Jaffee, MD, FAACR, Johns Hopkins University, moderated the third press conference.
Early Myocarditis Onset After Immunotherapy May Predict Treatment-related Fatality
- Presented by Hassan M. Abushukair, MD, Oklahoma University Stephenson Cancer Center
Intralesional Nivolumab May Be Effective Against Precancerous Oral Lesions
- Presented by Moran Amit, MD, PhD, The University of Texas MD Anderson Cancer Center
Exposure to Wildfire Smoke May Be Linked To Increased Risk of Developing Several Cancers
- Presented by Shuguang Leng, MBBS, PhD, The University of New Mexico Comprehensive Cancer Center
additional press releases
Long-term Use of Immunotherapy May Be Safe for Patients With Alveolar Soft Part Sarcoma
- Presented by Alice P. Chen, MD, National Cancer Institute, part of the National Institutes of Health
Distribution of Phase I Lung Cancer Trials May Be Consolidating at Top-performing U.S. Sites
- Presented by Brittany Avin McKelvey, PhD, LUNGevity Foundation